Former FDA commissioner Scott Gottlieb (Photo by Mark Wilson/Getty Images)
January 27, 2022 01:39 PM ESTUpdated 02:17 PM
Pharma

Scott Got­tlieb crit­i­cizes CMS in feud over Aduhelm cov­er­age, calls out their lack of ex­per­tise

Paul Schloesser

Associate Editor

For­mer FDA com­mis­sion­er and cur­rent Pfiz­er board mem­ber Scott Got­tlieb went on the of­fen­sive against CMS this morn­ing — cit­ing the agency’s “flawed de­ci­sion mak­ing” …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times